Topic: Food and Drug Administration
Approximately 40% of women interviewed in the National Health Interview Survey used complementary and alternative therapies of some kind in the 12 months before taking the survey.1 Of women in the midlife Study of Women Across the Nation (SWAN), this figure was ...
DEPO) posted positive earnings and gave shareholders a corporate update. We still believe Depomed has continued upside going forward based on short and long-term catalysts.. First, they said the FDA had approved the manufacturing site change for the 1000mg Glumetza. The investigation ...
Many women in the years of pre- menopause, menopause and post- menopause, frequently use Bioidentical Hormone Replacement Therapy to boost hormone activity reduced when growing old and to diminish indicators of hormone imbalance like hot flashes, night sweats , sadness, mood swings, ...
Ibandronic acid (INN ) or ibandronate sodium (USAN ) is marketed under the trade names Boniva , Bondronat and Bonviva . It is marketed and manufactured by GlaxoSmithKline and Roche Laboratories . GlaxoSmithKline has its headquarters in the UK with operations that ...
Menstruation (Greek Word, men ? month) is monthly uterine bleeding outflowing through vagina onto vulva for 4-5 days every 28 days during reproductive life of a women from menarche to menopause. stimulates hypothalamus and anterior pituitary to cause surge of LH and ...
Since the 2002 Women's Health Initiative study, bio-identical hormones have surged in popularity for menopause treatment. However, the FDA warned that bio-identical hormones have no safety advantage in 2008. Many menopause women are fighting with the FDA about this issue, and many ...
Women bothered by menopause-related hot flashes but reluctant to take hormone replacement therapy may soon have another FDA-approved option available to them. A new extended release version of the anticonvulsant drug gabapentin proved to be effective in both preventing and reducing the ...
It used to be that a woman experiencing menopause discomforts could visit her family physician and get the little happy pills that would make everything better; no, not prozac, but Premarin or Prempro. Decades later we have learned just how dangerous these ...
Bioidentical hormonereplacement therapy (BHRT) is one treatment option for addressing hormonedeficiencies. BHRT differs from traditional hormone therapy, inthat bioidentical hormones are made to be chemically identical to the naturallyoccurring female hormones, whereas traditional hormone replacement therapyutilizes chemicals that have been derived from ...
Depomed, Inc. (Nasdaq: DEPO) today announced presentations of clinical data of Breeze 1 and 2 at the North American Menopause Society (NAMS) Annual Meeting in Chicago, Illinois on October 8, 2010. Both Breeze 1 and 2 are Phase 3 trials that evaluated ...